219 related articles for article (PubMed ID: 31527831)
21. Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis.
Kim HI; Kim K; Park SY; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Ahn HS; Kim SW; Kim TH; Chung JH
Oral Oncol; 2018 Mar; 78():80-86. PubMed ID: 29496063
[TBL] [Abstract][Full Text] [Related]
22. Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study.
Kim M; Kim HI; Jeon MJ; Kim HK; Kim EH; Yi HS; Kim ES; Kim H; Kim BH; Kim TY; Kim SW; Kang HC; Kim WB; Chung JH; Shong YK; Kim TH; Kim WG
Oral Oncol; 2018 Dec; 87():97-103. PubMed ID: 30527251
[TBL] [Abstract][Full Text] [Related]
23. Comparison of long-term prognosis for differentiated thyroid cancer according to the 7th and 8th editions of the AJCC/UICC TNM staging system.
Kim K; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
Ther Adv Endocrinol Metab; 2020; 11():2042018820921019. PubMed ID: 32489582
[TBL] [Abstract][Full Text] [Related]
24. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
[TBL] [Abstract][Full Text] [Related]
25. An Analysis of The American Joint Committee on Cancer 8th Edition T Staging System for Papillary Thyroid Carcinoma.
Tran B; Roshan D; Abraham E; Wang L; Garibotto N; Wykes J; Campbell P; Ebrahimi A
J Clin Endocrinol Metab; 2018 Jun; 103(6):2199-2206. PubMed ID: 29672723
[TBL] [Abstract][Full Text] [Related]
26. Implementing the Modified 2009 American Thyroid Association Risk Stratification System in Thyroid Cancer Patients with Low and Intermediate Risk of Recurrence.
Pitoia F; Jerkovich F; Urciuoli C; Schmidt A; Abelleira E; Bueno F; Cross G; Tuttle RM
Thyroid; 2015 Nov; 25(11):1235-42. PubMed ID: 26132983
[TBL] [Abstract][Full Text] [Related]
27. Outcome prediction with the revised American joint committee on cancer staging system and American thyroid association guidelines for thyroid cancer.
Suh S; Kim YH; Goh TS; Lee J; Jeong DC; Oh SO; Hong JC; Kim SJ; Kim IJ; Pak K
Endocrine; 2017 Dec; 58(3):495-502. PubMed ID: 29030773
[TBL] [Abstract][Full Text] [Related]
28. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
[TBL] [Abstract][Full Text] [Related]
29. Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection--results of a single-institution study of 1343 Chinese patients.
Wang W; Xu DZ; Li YF; Guan YX; Sun XW; Chen YB; Kesari R; Huang CY; Li W; Zhan YQ; Zhou ZW
Ann Oncol; 2011 Sep; 22(9):2049-2056. PubMed ID: 21310759
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Utility of Tumor Stage versus American Thyroid Association Risk Class in Thyroid Cancer.
Abiri A; Pang J; Prasad KR; Goshtasbi K; Kuan EC; Armstrong WB; Haidar YM; Tjoa T
Laryngoscope; 2023 Jan; 133(1):205-211. PubMed ID: 35716358
[TBL] [Abstract][Full Text] [Related]
31. Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.
Kim M; Kim HK; Kim HI; Kim EH; Jeon MJ; Yi HS; Kim ES; Kim H; Kim TH; Kim BH; Kim TY; Kang HC; Kim WB; Chung JH; Shong YK; Kim SW; Kim WG
Oral Oncol; 2018 Nov; 86():48-52. PubMed ID: 30409319
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.
Zhi J; Wu Y; Hu L; Zhao J; Liu H; Ruan X; Hou X; Zhang J; Zheng X; Gao M
Int J Clin Oncol; 2020 Jan; 25(1):59-66. PubMed ID: 31414270
[TBL] [Abstract][Full Text] [Related]
33. Concepts of Pathological Staging and Prognosis in Papillary Thyroid Carcinoma.
Lam AK
Methods Mol Biol; 2022; 2534():109-119. PubMed ID: 35670971
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the Seventh and Eighth Editions of the American Joint Committee on Cancer/Union for International Cancer Control Tumor-Node-Metastasis Staging System for Differentiated Thyroid Cancer.
Kim M; Kim WG; Oh HS; Park S; Kwon H; Song DE; Kim TY; Shong YK; Kim WB; Sung TY; Jeon MJ
Thyroid; 2017 Sep; 27(9):1149-1155. PubMed ID: 28635571
[TBL] [Abstract][Full Text] [Related]
35. Modified lymph node ratio improves the prognostic predictive ability for breast cancer patients compared with other lymph node staging systems.
Jin ML; Gong Y; Pei YC; Ji P; Hu X; Shao ZM
Breast; 2020 Feb; 49():93-100. PubMed ID: 31783315
[TBL] [Abstract][Full Text] [Related]
36. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
[No Abstract] [Full Text] [Related]
37. Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size.
Kim HI; Kim TH; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Jang HW; Kim YN; Kim H; Ahn HS; Kim K; Kim SW; Chung JH
Cancer Med; 2017 Oct; 6(10):2244-2251. PubMed ID: 28857489
[TBL] [Abstract][Full Text] [Related]
38. Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM.
Sapuppo G; Grasso S; Di Benedetto G; Belfiore A; Pellegriti G
Front Endocrinol (Lausanne); 2023; 14():1128963. PubMed ID: 36992807
[TBL] [Abstract][Full Text] [Related]
39. Comparison between the seventh and eighth edition of the AJCC/UICC staging system for nasopharyngeal cancer integrated with pretreatment plasma Epstein-Barr virus DNA level in a non-Chinese population: secondary analysis from a prospective randomized trial.
Kitpanit S; Jittapiromsak N; Sriyook A; Prayongrat A; Kannarunimit D; Chakkabat C; Lertbutsayanukul C
Jpn J Clin Oncol; 2019 Dec; 49(12):1100-1113. PubMed ID: 31334768
[TBL] [Abstract][Full Text] [Related]
40. The effects of the Union for International Cancer Control/American Joint Committee on Cancer Tumour, Node, Metastasis system version 8 on staging of differentiated thyroid cancer: a comparison to version 7.
Verburg FA; Mäder U; Luster M; Reiners C
Clin Endocrinol (Oxf); 2018 Jun; 88(6):950-956. PubMed ID: 29573277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]